Developing a European Framework for Research on Children’s Medicines

An Examination of the Proposed EU Regulation on Medicinal Products for Paediatric Use; 25–26 January 2005, Brussels, Belgium
  • Hannsjörg W. Seyberth
  • Jacques Demotes-Mainard
  • Peter Wrobel
Meeting Report


Joint United Nations Programme Paediatric Clinical Trial Proposed Regulation European Clinical Research Infrastructure Network Paediatric Clinical Research 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



© European Forum for Good Clinical Practice (EFGCP), 2005. All rights in this document are reserved by the EFGCP, a not-for-profit organisation chartered under Belgian law. The EFGCP hereby gives permission for this document to be freely reviewed, abstracted, reproduced, or translated, provided it receives a copy of such. This document may not be sold in conjunction with commercial purposes without the express written permission of the EFGCP.

The conference received funding from Boehringer Ingelheim; Chiesi Farmaceutici SpA; Genzyme; GlaxoSmithKline Biologicals; Hoffman-La Roche Pharmaceuticals; Les Pharmaceutical Enterprises du Médicament (LEEM); Novartis Pharmaceuticals; Pfizer UK; Pharmaceutical Research & Manufacturers of America (PhRMA); Schering AG; Schering Plough; Solvay Pharmaceuticals.

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  • Hannsjörg W. Seyberth
    • 1
  • Jacques Demotes-Mainard
    • 2
  • Peter Wrobel
    • 3
  1. 1.Philipps UniversityMarburgGermany
  2. 2.Institut National de la Santé et de la Recherche Médicale (INSERM)BordeauxFrance
  3. 3.European Forum for Good Clinical PracticeBrusselsBelgium

Personalised recommendations